In support of this, here we show increased cytotoxic activity in response to gemcitabine chemotherapy, as demonstrated by an increase in Granzyme B. We also show that gemcitabine induces anemia in the form of reduced levels of hematocrit, hemoglobin and RBCs. The gene discussed is GZMB; the disease is anemia.